Drawing for PREVADE

USPTO serial 85207998

PREVADE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
YOUNG, CARRIE SKYE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PREVADE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals, anthelmintics, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheepACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 30, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 29, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 28, 2011EX1GSOU EXTENSION 1 GRANTED
Nov 28, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 17, 2011EXT1SOU EXTENSION 1 FILED
Nov 17, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 3, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2011DOCKASSIGNED TO EXAMINER
Jan 7, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance